The mutational burden of cSCC is extremely high, and it includes mutations in TP53, CDKN2A, NOTCH1 and NOTCH2, with mutations in TP53 being the most common [29,32,38,48,49]. This evidence concerns the gene TP53 and skin squamous cell carcinoma.